SCHEMBL3759696

SCHEMBL3759696

CN(C)c1cccc(-c2cc(-c3c(N4CCOCC4)sc4c3CC(C)(C)CC4=O)ccn2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.41
HTT P42858 2/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
GABRA1 P14867 4/20 0.37
GABRG2 P18507 4/20 0.37
GABRB3 P28472 4/20 0.37
GABRA5 P31644 4/20 0.37
GABRA3 P34903 4/20 0.37
GABRA2 P47869 4/20 0.37
BUB1 O43683 1/20 0.37
PIK3CD O00329 4/20 0.37
PIK3CA P42336 4/20 0.37
PIK3CB P42338 4/20 0.37
PIK3CG P48736 4/20 0.37
PIK3R2 O00459 1/20 0.36
ATR Q13535 1/20 0.36
ATRIP Q8WXE1 1/20 0.36
RIPK3 Q9Y572 1/20 0.35
FYN P06241 1/20 0.35
GRIA1 P42261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3769311 0.91 HTT (0.46) SMN1; SMN2HTTCTDSP1GABRA1GABRG2
SCHEMBL16161713 0.91 PIK3CD (0.38) SMN1; SMN2HTTCTDSP1GABRA1GABRG2
SCHEMBL3758946 0.90 HTT (0.44) SMN1; SMN2HTTCTDSP1GABRA1GABRG2
SCHEMBL3762158 0.89 LRRK2 (0.38) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL3766682 0.89 KDM1A (0.40) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL3764482 0.89 BUB1 (0.44) SMN1; SMN2GABRA1GABRG2GABRB3GABRA5
SCHEMBL3762316 0.89 LRRK2 (0.41) SMN1; SMN2GABRA1GABRG2GABRB3GABRA5
SCHEMBL3760222 0.88 PIK3CA (0.45) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL3756713 0.88 JAK2 (0.40) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL3763765 0.88 AOC3 (0.38) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA SMN1; SMN2 1864/4885HTT 1234/4885CTDSP1 3461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.